S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
Log in

NYSE:NGVTIngevity Stock Price, Forecast & News

$58.29
-0.19 (-0.32 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$57.94
Now: $58.29
$59.67
50-Day Range
$47.31
MA: $54.28
$60.05
52-Week Range
$24.92
Now: $58.29
$94.67
Volume279,766 shs
Average Volume514,769 shs
Market Capitalization$2.40 billion
P/E Ratio14.46
Dividend YieldN/A
Beta2.42
Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process and caprolactone. This segment's products are used in various applications comprising pavement preservation, pavement adhesion promotion and warm mix paving, oil well service additives, oil production and downstream application chemicals, printing inks, adhesives, agrochemicals, lubricants and industrial intermediates, coatings resins, elastomers, adhesives, and bio-plastics. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina.
Read More
Ingevity logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.70 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
Previous SymbolNASDAQ:NGVT
CUSIPN/A
Phone843-740-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.29 billion
Cash Flow$6.99 per share
Book Value$12.69 per share

Profitability

Net Income$183.70 million

Miscellaneous

Employees1,850
Market Cap$2.40 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$58.29
-0.19 (-0.32 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NGVT News and Ratings via Email

Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ingevity (NYSE:NGVT) Frequently Asked Questions

How has Ingevity's stock been impacted by COVID-19 (Coronavirus)?

Ingevity's stock was trading at $38.80 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NGVT shares have increased by 50.2% and is now trading at $58.29.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Ingevity?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Ingevity
.

When is Ingevity's next earnings date?

Ingevity is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Ingevity
.

How were Ingevity's earnings last quarter?

Ingevity Corp (NYSE:NGVT) issued its quarterly earnings results on Wednesday, July, 29th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.03. The firm had revenue of $270.60 million for the quarter, compared to analysts' expectations of $256.30 million. Ingevity had a return on equity of 36.42% and a net margin of 13.89%. The company's quarterly revenue was down 23.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.36 EPS.
View Ingevity's earnings history
.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, July, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.1-1.2 billion, compared to the consensus revenue estimate of $1.14 billion.

What price target have analysts set for NGVT?

6 analysts have issued 1-year price objectives for Ingevity's stock. Their forecasts range from $55.00 to $94.00. On average, they anticipate Ingevity's share price to reach $71.50 in the next twelve months. This suggests a possible upside of 22.7% from the stock's current price.
View analysts' price targets for Ingevity
.

Has Ingevity been receiving favorable news coverage?

News articles about NGVT stock have trended negative on Monday, InfoTrie reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Ingevity earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next several days.
View the latest news about Ingevity
.

Are investors shorting Ingevity?

Ingevity saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 1,400,000 shares, a decrease of 11.4% from the June 15th total of 1,580,000 shares. Based on an average daily volume of 516,700 shares, the days-to-cover ratio is presently 2.7 days. Currently, 3.4% of the shares of the company are short sold.
View Ingevity's Current Options Chain
.

Who are some of Ingevity's key competitors?

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include AbbVie (ABBV), Pfizer (PFE), Verizon Communications (VZ), Costco Wholesale (COST), Dominion Energy (D), General Electric (GE), Quaker Chemical (KWR), Boeing (BA), Alibaba Group (BABA) and Walt Disney (DIS).

Who are Ingevity's key executives?

Ingevity's management team includes the following people:
  • Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)
  • Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)
  • Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)
  • Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58)

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Ardevora Asset Management LLP (2.06%), Aperture Investors LLC (0.63%), Patten & Patten Inc. TN (0.35%), Raymond James & Associates (0.26%), Ingalls & Snyder LLC (0.23%) and New York State Teachers Retirement System (0.19%). Company insiders that own Ingevity stock include D Michael Wilson, Diane H Gulyas, Frederick J Lynch, John C Fortson, Katherine Pryor Burgeson, Michael P Smith, Phillip John Platt and Richard B Kelson.
View institutional ownership trends for Ingevity
.

Which institutional investors are selling Ingevity stock?

NGVT stock was sold by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Dupont Capital Management Corp, SG Americas Securities LLC, Ingalls & Snyder LLC, Lapides Asset Management LLC, Patten & Patten Inc. TN, First Trust Advisors LP, and Nisa Investment Advisors LLC.
View insider buying and selling activity for Ingevity
.

Which institutional investors are buying Ingevity stock?

NGVT stock was purchased by a variety of institutional investors in the last quarter, including Aperture Investors LLC, Hodges Capital Management Inc., Raymond James & Associates, Moody Aldrich Partners LLC, ProShare Advisors LLC, Assenagon Asset Management S.A., Janney Montgomery Scott LLC, and M&T Bank Corp. Company insiders that have bought Ingevity stock in the last two years include D Michael Wilson, Diane H Gulyas, Frederick J Lynch, John C Fortson, Michael P Smith, and Richard B Kelson.
View insider buying and selling activity for Ingevity
.

How do I buy shares of Ingevity?

Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $58.29.

How big of a company is Ingevity?

Ingevity has a market capitalization of $2.40 billion and generates $1.29 billion in revenue each year. The company earns $183.70 million in net income (profit) each year or $4.93 on an earnings per share basis. Ingevity employs 1,850 workers across the globe.

What is Ingevity's official website?

The official website for Ingevity is www.ingevity.com.

How can I contact Ingevity?

Ingevity's mailing address is 5255 Virginia Avenue, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.